References
- Patnaik M, Schwartzman WA, Barka N, Peter JB. Possible role of Rochalimaea henselae in pathogenesis of AIDS encephalopathy. Lancet 1992; 340: 971.
- Schwartzman WA, Patnaik M, Barka NE, Peter JB. Rochalimaea antibodies in HIV-associated neurologic disease. Neurology 1994; 44: 1312–6.
- Schwartzman WA, Patnaik M, Angulo FJ, Visscher BR, Miller EN, Peter JB. Bartonella (Rochalimae) antibodies, dementia, and cat ownership among men infected with human immunodefiency virus. Clin Infect Dis 1995; 21: 954–9.
- Schwartzman WA, Patnaik M, Singer E, Visscher B. Featuresof Bartonella-associated HIV dementias. Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1998.
- Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, et al. The HNRC 500–Neuropsychology of HIV infection at different disease stages Journal of the International Neuropsychological Society, 1995; 1: 231–251.
- HNRC Group, Heaton RK, Kirson D, Velin RA, Grant I. The utility of clinical ratings for detecting early cognitive change in HIV infection. In: Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press, 1994: 188–206.
- Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol 1990; 12: 963–78.
- Zbinden R, Michael N, Sekulovski M, Graevenitz A, von Nadal D. Evaluation of commercial slides for detection of immunoglobulin G against Bartonella henselae. Eur J Clin Microbiol Infect Dis 1997; 16: 648–52.
- Teichberg S, Farber BF, Wolff AG, Roberts B. EIA for detection of Rochalimaea henselae-reactiveIgG, IgM, and IgA antibodies in patients with suspected cat-scratch disease. J Infect Dis 1993; 167: 1503–4.
- Zangwill KM, Douglas DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL, et al. Cat scratch disease in Connecticut. N Engl J Med 1993; 329: 8–13.
- Bergmans AM, Groothedde JW, Schellekens JF, van Embden JD, Ossewaarde JM, Schouls LM. Etiology of cat scratch disease: comparison of polymerase chain reaction detection of Bartonella (formerly Rochalimaea) and Afipia felis DNA with serology and skin tests. J Infect Dis 1995; 171: 916–23.
- Yousif A, Farid I, Baig B, Creek J, Olson P, Wallace M. Prevalence of Bartonella henselae antibodies among human immunodeficiency virus-infected patients from Bahrain. Clin Infect Dis 1996; 23: 398–9.
- Regnery RI, Olson JG, Perkins BA, Bibb W. Serological response to “Rochalimaea henselae” in suspected cat-scratch disease. Lancet 1992; 339: 1443–5.
- Carithers HA Margileth AM, Cat-Scratch American Journal of Disease of Children, 1991; 145: 98–101.
- Lyon LW. Neurologic manifestations of cat-scratch disease. Arch Neurol 1971; 25: 23–7.
- Lewis LW Tucker SH, Central nervous system involvement in cat scratch disease, Pediatrics 1986; 77 714–21
- Case Records of the Massachusetts General Hospital, Case 1–1998. N Engl J Med 1998; 112–119. Vol 338
- Marra CM. Neurologic complications of Bartonella henselae infection. Neurology 1995; 8: 164–9.
- Baker J, Ruiz-Rodriguez R, Whitfeld M, Heon V, Berger TG. Bacillary angiomatosis: a treatable cause of acute psychiatric symptoms in human immunodeficiency virus infection. J Clin Psychiatry 1995; 56: 161–6.
- Spach DH, Panther LA, Thorning DR, Dunn JE, Plorde JJ, Miller RA. Intracerebral bacillary angiomatosis in a patient infected with human immunodeficiency virus. Ann Intern Med 1992; 116: 740–2.
- George TI, Manley G, Koehler JE, Hung VS, McDermott M, Bollen A. Detection of Bartonella henselae by polymerase chain reaction in brain tissue of an immunocompromised patient with multiple enhancing lesions. J Neurosurg 1998; 89: 640–4.